Using the high-dose corticotropin test to diagnose relative adrenal insufficiency in vasopressor-dependent septic shock

American Journal of Health-System Pharmacy

Volumn 63, Issue 5, 2006, Pages 466-471

  Szumita, Paul M ^a,b   Greenwood, Bonnie C ^a   Lowry, Colleen M ^b   Wechsler, Michael E ^b,c  

^a Department of Pharmacy ^*  (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOTROPIN; FLUDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; HYPERTENSIVE FACTOR; NORADRENALIN; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL PRACTICE; CORTICOTROPIN TEST; DECISION MAKING; DIAGNOSTIC VALUE; DRUG MEGADOSE; EXPERIENCE; HUMAN; INFORMATION CENTER; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROBLEM SOLVING; SEPTIC SHOCK;

EID: 33644689689     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050359     Document Type: Article

References (32)

1. Sasse KC, Nauenberg E, Long A et al. Long-term survival after intensive care unit admission with sepsis. Crit Care Med. 1995; 23:1040-7.
2. Vyhnanek F, Vanecek M, Helfert I et al. The effects of hydrocortisone and dopamine on circulatory alterations in experimental endotoxin shock in dogs. Exp Chir. 1978; 11:322-7.
3. Kozyra E, Wax R, Burry L. Can 1μg of cosyntropin be used to evaluate adrenal insufficiency in critically ill patients? Ann Pharmacother. 2005; 39:691-8.
4. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996; 335:1206-12.
5. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003; 348:727-34.
6. Altura BM. Glucocorticoid-induced protection in circulatory shock: role of the reticuloendothelial system function. Proc Soc Exp Biol Med. 1975; 150:202-6.
7. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002; 287:236-40.
8. Burry L, Wax R. Role of corticosteroids in septic shock. Ann Pharmacother. 2004; 38:464-72.
9. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg. 1976; 184:333-41.
10. Bone RC, Fisher CJ, Clemmer TP et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987; 317:653-8.
11. Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med. 1987; 317:659-65.
12. Sprung CL, Caralis PV, Marcial EH et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med. 1984; 311:1137-43.
13. Lefering R, Neugebauer A. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med. 1995; 1294-303.
14. Cronin L, Cook DJ, Carlet J et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995; 23:1430-9.
15. Briegel F, Forst H, Haller M et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999; 27:723-32.
16. Chawla K, Kupfer Y, Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med. 1999; 27:A33. Abstract.
17. Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288:862-71.
18. Bollaert PE, Charpentier C, Levy G et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998; 26:645-50.
19. Rivers EP, Gaspari M, Saad GA et al. Adrenal insufficiency in high-risk surgical ICU patients. Chest. 2001; 119:889-95.
20. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32:858-73.
21. Dorin RI, Quails CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med. 2003; 139:194-204.
22. Marik P, Zaloga G. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest. 2002; 122:1784-96.
23. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med. 2003; 31:141-5.
24. American College of Chest Physicians and Society of Critical Care Medicine Consensus Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20:864-74.
25. Baroletti S, Szumita P. PIES method of critique. Crit Pathways Cardiol. 2004; 3:205-8.
26. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004; 350:1629-38.
27. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1360-7.
28. Finney SJ, Zekveld C, Elia A et al. Glucose control and mortality in critically ill patients. JAMA. 2003; 290:2041-7.
29. Van den Berghe G, Wouters PJ, Bouillon R et al. Outcome benefits of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003; 31:359-66.
30. Annane D, Sebille V, Troche G et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000; 283:1038-45.
31. Manglik S, Flores E, Lubarsky L et al. Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial. Crit Care Med. 2003; 31:1668-75.
32. Yildiz O, Doganay M, Aygen B et al. Physiological-dose steroid therapy in sepsis. Crit Care. 2002; 6:251-8.